(Q42150030)

English

Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease

scientific article published on January 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

pelvic inflammatory diseases

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Ibrahim S

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Derde MP

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Kaufman L

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Clerckx-Braun F

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Jacqmin P

5

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Brulein V

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Donnez J

7

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Tulkens PM

8

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

publication date

1 January 1990

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

199-203

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Aminoglycoside research 1975-1985: prospects for development of improved agents

1 reference

https://api.crossref.org/works/10.3109%2F08860229009065564

21 January 2018

Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits

1 reference

https://api.crossref.org/works/10.3109%2F08860229009065564

21 January 2018

The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure

1 reference

https://api.crossref.org/works/10.3109%2F08860229009065564

21 January 2018

The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess

1 reference

https://api.crossref.org/works/10.3109%2F08860229009065564

21 January 2018

Nephrotoxicity of aminoglycoside antibiotics.

1 reference

https://api.crossref.org/works/10.3109%2F08860229009065564

21 January 2018

Kinetic model for gentamicin dosing with the use of individual patient parameters

1 reference

https://api.crossref.org/works/10.3109%2F08860229009065564

21 January 2018

Aminoglycoside-induced hearing loss in humans

1 reference

https://api.crossref.org/works/10.3109%2F08860229009065564

21 January 2018

Identifiers

10.3109/08860229009065564

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42150030&oldid=2143767705"